Literature DB >> 12085274

[Comparison between treatment results for gastric cancer in younger and elderly patients].

P Piso1, H Bektas, U Werner, T Becker, H Aselmann, H J Schlitt, J Klempnauer.   

Abstract

INTRODUCTION: While gastric cancer shows an increased incidence in elderly patients, the rate of younger patients affected by this disease represents up to 15 %. Younger patients are frequently diagnosed with advanced tumor stages with a poor prognosis although literature data on this issue are controversial. PATIENTS AND METHODS: 643 patients with primary gastric carcinoma were operated in our institution between March 1986 and December 2000. No neoadjuvant treatment was administered in these patients. We analysed the data of these patients retrospectively. A comparison of the results between patients younger than 40 years (n = 38, median age 37 years) and older than 70 years (n = 182, median age 75 years) was performed.
RESULTS: The radical (R0-) resectability rate was rather high for both, younger (78.9 %) and elderly (76.9 %) patients. Postoperative morbidity was higher in elderly than in younger patients (32.9 % vs. 23.2 %; p < 0.05), as well as the postoperative mortality (7.7 % vs. 2.6 %; p < 0.05). Both younger and elderly patients showed advanced (II to IV) tumor stages (76.3 % vs. 73.3 %, n. s.). There was a significant difference between the rate of diffuse carcinomas in young and elderly patients (63.2 % vs. 22.5 %). The 5-years survival rate following R0-resection was significantly higher for younger patients (54.2 % vs. 32.9 %; p = 0.01), differences occurred only after the second postoperative year.
CONCLUSIONS: The resectability of gastric carcinoma is not related to the patients age. Due to comorbidity, postoperative morbidity may be increased in elderly patients. Although both younger and elderly patients show advanced tumor stages, diffuse carcinomas are more frequent in younger patients. The short-term prognosis is similar for both age groups, long-term results are better for younger patients. The different life expectancy should be considered when interpreting these results.

Entities:  

Mesh:

Year:  2002        PMID: 12085274     DOI: 10.1055/s-2002-31553

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  7 in total

1.  Clinicopathologic characteristics of serosa-positive gastric carcinoma in elderly patients.

Authors:  Ho Gun Kim; Hyo Kang; Dong Yi Kim; Jae Kyoon Joo; Seong Yeob Ryu; Jae Hyuk Lee
Journal:  J Korean Surg Soc       Date:  2011-07-11

2.  Clinicopathologic characteristics of gastric carcinoma in elderly patients: a comparison with young patients.

Authors:  Dong-Yi Kim; Jae-Kyoon Joo; Seong-Yeob Ryu; Young-Kyu Park; Young-Jin Kim; Shin-Kon Kim
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Clinicopathological comparison between young and old age patients with gastric adenocarcinoma.

Authors:  Kamal E Bani-Hani
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer.

Authors:  Yves Dittmar; Falk Rauchfuss; Max Götz; Hubert Scheuerlein; Karin Jandt; Utz Settmacher
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

5.  Gastric cancer surgery in elderly patients.

Authors:  Stephen Gretschel; Lope Estevez-Schwarz; Michael Hünerbein; Ulrike Schneider; Peter M Schlag
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

6.  E-PASS Scoring System May Be Useful for Prediction of Postoperative Complications in Super Elderly Colorectal Cancer Surgery Patients.

Authors:  Hiroka Kondo; Yasumitsu Hirano; Toshimasa Ishii; Kiyoka Hara; Nao Obara; Liming Wang; Masahiro Asari; Takuya Kato; Shigeki Yamaguchi
Journal:  J Anus Rectum Colon       Date:  2020-07-30

7.  Gastric cancer in the young: is it a different clinical entity? A retrospective cohort study.

Authors:  Adolfo Pisanu; Mauro Podda; Alessandro Cois; Alessandro Uccheddu
Journal:  Gastroenterol Res Pract       Date:  2014-02-13       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.